Download PDF
Semin Thromb Hemost 2017; 43(04): 416-422
DOI: 10.1055/s-0037-1599159
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Point-of-Care Testing in Neurosurgery

Christopher Beynon
1   Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
,
Lars Wessels
1   Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
,
Andreas W. Unterberg
1   Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
27 March 2017 (online)

    Permissions and Reprints

Abstract

Coagulation disorders can have a major impact on the outcome of neurosurgical patients. The central nervous system is located within the closed space of the skull, and therefore, intracranial hemorrhage can lead to intracranial hypertension. Acute brain injury has been associated with alterations of various hemostatic parameters. Point-of-care (POC) techniques such as rotational thromboelastometry are able to identify markers of coagulopathy which are not reflected by standard assessment of hemostasis (e.g., hyperfibrinolysis). In patients with acute brain injury, POC test results have been associated with important outcome parameters such as mortality and need for neurosurgical intervention. POC devices have also been used to rapidly identify and quantify the effects of antithrombotic medication. In cases of life-threatening intracranial hemorrhage, this information can be valuable when deciding over administration of prohemostatic substances or immediate neurosurgical intervention. In elective neurosurgical procedures, POC devices can provide important information when unexpected bleeding occurs or in cases of prolonged operative time with subsequent blood loss. Initial experiences with POC devices in neurosurgical care have shown promising results but further studies are needed to characterize their full potential and limitations.

Keywords

intracranial hemorrhage - coagulation - antithrombotic medication - craniotomy - bedside testing
 

  • References

  • 1 Naidech AM, Kumar MA. ; Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring. Monitoring of hematological and hemostatic parameters in neurocritical care patients. Neurocrit Care 2014; 21 (Suppl. 02) S168-S176
    CrossrefPubMedGoogle Scholar
  • 2 Rolston JD, Han SJ, Lau CY, Berger MS, Parsa AT. Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg 2014; 120 (03) 736-745
    CrossrefPubMedGoogle Scholar
  • 3 Abdelmalik PA, Boorman DW, Tracy J, Jallo J, Rincon F. Acute traumatic coagulopathy accompanying isolated traumatic brain injury is associated with worse long-term functional and cognitive outcomes. Neurocrit Care 2016; 24 (03) 361-370
    CrossrefPubMedGoogle Scholar
  • 4 Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009; 67 (01) 125-131
    CrossrefPubMedGoogle Scholar
  • 5 Karni A, Holtzman R, Bass T. , et al. Traumatic head injury in the anticoagulated elderly patient: a lethal combination. Am Surg 2001; 67 (11) 1098-1100
    PubMedGoogle Scholar
  • 6 Ferraris VA, Brown JR, Despotis GJ. , et al; Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion; International Consortium for Evidence Based Perfusion. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91 (03) 944-982
    CrossrefPubMedGoogle Scholar
  • 7 Seelig JM, Becker DP, Miller JD, Greenberg RP, Ward JD, Choi SC. Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours. N Engl J Med 1981; 304 (25) 1511-1518
    CrossrefPubMedGoogle Scholar
  • 8 Kuramatsu JB, Gerner ST, Schellinger PD. , et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 2015; 313 (08) 824-836
    CrossrefPubMedGoogle Scholar
  • 9 Combescure C, Fontana P, Mallouk N. , et al; CLOpidogrel and Vascular ISchemic Events Meta-analysis Study Group. Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis. J Thromb Haemost 2010; 8 (05) 923-933
    PubMedGoogle Scholar
  • 10 Da Luz LT, Nascimento B, Shankarakutty AK, Rizoli S, Adhikari NK. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014; 18 (05) 518
    CrossrefPubMedGoogle Scholar
  • 11 Kreitzer NP, Bonomo J, Kanter D, Zammit C. Review of thromboelastography in neurocritical care. Neurocrit Care 2015; 23 (03) 427-433
    CrossrefPubMedGoogle Scholar
  • 12 Tian H-L, Chen H, Wu B-S. , et al. D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases. Neurosurg Rev 2010; 33 (03) 359-365 , discussion 365–366
    CrossrefPubMedGoogle Scholar
  • 13 Schöchl H, Solomon C, Traintinger S. , et al. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma 2011; 28 (10) 2033-2041
    CrossrefPubMedGoogle Scholar
  • 14 Kunio NR, Differding JA, Watson KM, Stucke RS, Schreiber MA. Thrombelastography-identified coagulopathy is associated with increased morbidity and mortality after traumatic brain injury. Am J Surg 2012; 203 (05) 584-588
    CrossrefPubMedGoogle Scholar
  • 15 Windeløv NA, Welling K-L, Ostrowski SR, Johansson PI. The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis. Blood Coagul Fibrinolysis 2011; 22 (05) 416-419
    CrossrefPubMedGoogle Scholar
  • 16 Nekludov M, Bellander B-M, Blombäck M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma 2007; 24 (11) 1699-1706
    CrossrefPubMedGoogle Scholar
  • 17 Davis PK, Musunuru H, Walsh M. , et al. Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy. Neurocrit Care 2013; 18 (02) 201-208
    CrossrefPubMedGoogle Scholar
  • 18 Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15
    CrossrefPubMedGoogle Scholar
  • 19 Görlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schöchl H. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012; 39 (02) 104-113
    CrossrefPubMedGoogle Scholar
  • 20 Kawano-Castillo J, Ward E, Elliott A. , et al. Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement. Stroke 2014; 45 (03) 683-688
    CrossrefPubMedGoogle Scholar
  • 21 Ramchand P, Nyirjesy S, Frangos S. , et al. Thromboelastography parameter predicts outcome after subarachnoid hemorrhage: an exploratory analysis. World Neurosurg 2016; 96: 215-221
    CrossrefPubMedGoogle Scholar
  • 22 Frontera JA, Provencio JJ, Sehba FA. , et al. The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage. Neurocrit Care 2017; 26 (01) 48-57
    CrossrefPubMedGoogle Scholar
  • 23 van den Bergh WM, Algra A, Dorhout Mees SM. , et al; MASH Study Group. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study. Stroke 2006; 37 (09) 2326-2330
    CrossrefPubMedGoogle Scholar
  • 24 Wikkelsø A, Wetterslev J, Møller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev 2016; (08) CD007871
    PubMedGoogle Scholar
  • 25 Haas T, Goobie S, Spielmann N, Weiss M, Schmugge M. Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM(®) -assisted strategy - feasibility and costs. Paediatr Anaesth 2014; 24 (07) 774-780
    CrossrefPubMedGoogle Scholar
  • 26 Naik BI, Pajewski TN, Bogdonoff DI. , et al. Rotational thromboelastometry-guided blood product management in major spine surgery. J Neurosurg Spine 2015; 23 (02) 239-249
    CrossrefPubMedGoogle Scholar
  • 27 Naik BI, Durieux ME, Knisely A. , et al. SEER sonorheometry versus rotational thromboelastometry in large volume blood loss spine surgery. Anesth Analg 2016; 123 (06) 1380-1389
    CrossrefPubMedGoogle Scholar
  • 28 Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage. J Neurol 2012; 259 (02) 212-224
    CrossrefPubMedGoogle Scholar
  • 29 Rossaint R, Bouillon B, Cerny V. , et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100
    CrossrefPubMedGoogle Scholar
  • 30 Beynon C, Jakobs M, Rizos T, Unterberg AW, Sakowitz OW. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients. Br J Neurosurg 2014; 28 (01) 29-33
    CrossrefPubMedGoogle Scholar
  • 31 Rizos T, Jenetzky E, Herweh C. , et al. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage. Ann Neurol 2010; 67 (06) 788-793
    PubMedGoogle Scholar
  • 32 Beynon C, Potzy A, Sakowitz OW. Point-of-care testing in anticoagulation reversal. Thromb Res 2015; 135 (06) 1218-1220
    CrossrefPubMedGoogle Scholar
  • 33 Levi M. Safety of prohemostatic interventions. Semin Thromb Hemost 2012; 38 (03) 292-298
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Khorsand N, Kooistra HAM, van Hest RM, Veeger NJGM, Meijer K. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy. Thromb Res 2015; 135 (01) 9-19
    CrossrefPubMedGoogle Scholar
  • 35 Becattini C, Franco L, Beyer-Westendorf J. , et al. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life. Int J Cardiol 2017; 227: 261-266
    CrossrefPubMedGoogle Scholar
  • 36 Franchini M, Bonfanti C, Mannucci PM. Management of bleeding associated with new oral anticoagulants. Semin Thromb Hemost 2015; 41 (07) 788-801
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Pollack Jr CV, Reilly PA, Eikelboom J. , et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015; 373 (06) 511-520
    CrossrefPubMedGoogle Scholar
  • 38 Harenberg J, Du S, Krämer S. , et al. Novel methods for assessing oral direct factor Xa and thrombin inhibitors: use of point-of-care testing and urine samples. Semin Thromb Hemost 2013; 39 (01) 66-71
    PubMedGoogle Scholar
  • 39 Ebner M, Peter A, Spencer C. , et al. Point-of-care testing of coagulation in patients treated with non-vitamin K antagonist oral anticoagulants. Stroke 2015; 46 (10) 2741-2747
    CrossrefPubMedGoogle Scholar
  • 40 Naidech AM, Liebling SM, Rosenberg NF. , et al. Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care 2012; 16 (01) 82-87
    CrossrefPubMedGoogle Scholar
  • 41 Joseph B, Pandit V, Sadoun M. , et al. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg 2013; 75 (06) 990-994
    CrossrefPubMedGoogle Scholar
  • 42 Karger R, Reuter K, Rohlfs J, Nimsky C, Sure U, Kretschmer V. The platelet function analyzer (PFA-100) as a screening tool in neurosurgery. ISRN Hematol 2012; 2012: 839242
    PubMedGoogle Scholar
  • 43 Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35 (06) 1061-1064 , discussion 1064–1065
    CrossrefPubMedGoogle Scholar
  • 44 Fabbri A, Servadei F, Marchesini G, Bronzoni C, Montesi D, Arietta L. ; Società Italiana di Medicina d'Emergenza Urgenza Study Group. Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study. Crit Care 2013; 17 (02) R53
    CrossrefPubMedGoogle Scholar
  • 45 Beynon C, Scherer M, Jakobs M, Jung C, Sakowitz OW, Unterberg AW. Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies. Clin Neurol Neurosurg 2013; 115 (10) 2003-2008
    CrossrefPubMedGoogle Scholar
  • 46 Prinz V, Finger T, Bayerl S. , et al. High prevalence of pharmacologically induced platelet dysfunction in the acute setting of brain injury. Acta Neurochir (Wien) 2016; 158 (01) 117-123
    CrossrefPubMedGoogle Scholar
  • 47 Bachelani AM, Bautz JT, Sperry JL. , et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery 2011; 150 (04) 836-843
    CrossrefPubMedGoogle Scholar
  • 48 Goh C, Churilov L, Mitchell P, Dowling R, Yan B. Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 2013; 34 (04) 721-726
    CrossrefPubMedGoogle Scholar
  • 49 Kass-Hout T, Alderazi YJ, Amuluru K. , et al. Neurointerventional stenting and antiplatelet function testing: to do or not to do?. Interv Neurol 2015; 3 (3-4): 184-189
    PubMedGoogle Scholar
  • 50 Price MJ, Berger PB, Teirstein PS. , et al; GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 2011; 305 (11) 1097-1105
    CrossrefPubMedGoogle Scholar
  • 51 Laroche M, Kutcher ME, Huang MC, Cohen MJ, Manley GT. Coagulopathy after traumatic brain injury. Neurosurgery 2012; 70 (06) 1334-1345
    CrossrefPubMedGoogle Scholar